ONCOLOGY
PEER-REVIEWED
HIGHLIGHTS FROM THE
European Society for
Medical Oncology
2015 European Lung
Cancer Conference
PEER-REVIEWED HIGHLIGHTS
April 15-18, 2015
Geneva, Switzerland
IN THIS ISSUE
Immunotherapy Is Evolving
and Promising for Lung Cancer
Promising immunotherapies are in development for lung cancer. Many combinations with
these drugs are being investigated, though caution on provoking the immune system is
needed. Anti-cancer vaccines have had limited success for lung cancer. Finally, clinical trials
are evolving as therapies rapidly change. See page 28.
ALSO
Patient-Based Therapy
for Non-Small Cell
Lung Cancer
1-781-897-5249
mdce@sagepub.com
www.mdconferencexpress.com
Clinical
Trial
Highlights
Optimizing Radiation
Therapy for Small
Cell Lung Cancer
visit us, like us, and subscribe
http://www.mdconferencexpress.comhttp://www.mdconferencexpress.com
Table of Contents for the Digital Edition of MD Conference Express - ELCC 2015